Fundraising FoxOrbiMed — 2023 Investments
9 investments dated 2023 · listed companies and verified rows first · show all
MinervaX is a biotech company developing prophylactic vaccines, with therapeutic focus areas including immunology and infectious disease.
BiotechHealthtech
PerBengt(CSO)
Co-investorsAdjuvant CapitalIndustrifondenPureos BioventuresSanofi VenturesSunstone CapitalEQT Life Sciences+2 more
Convergent Therapeutics develops radioantibody-based (PSMA-targeted) therapies for cancers, including metastatic castration-resistant prostate cancer (mCRPC).
BiotechHealthtechCambridge, US
Philip Kantoff(Chief Executive Officer, Co-Founder)inNeil Bander(Senior Scientific Advisor, Co-Founder)Alexander Brown(Executive Officer)inAndrew Davis(Chief Business and Strategy Officer)inElizabeth L. Montgomery(Chief People Officer)inEric M. Sullivan(Chief Financial Officer)in
Board seatTal Zaks· per SEC Form D
Co-investorsInvusRA Capital
46 Capital is an investment firm focused on early-stage companies across multiple sectors, led by experienced professionals with backgrounds in venture capital, private equity, healthcare, energy, and finance.
Fintech
Tim Clark(Managing Director)
Co-investorsHurricane VenturesAndreessen HorowitzAscenta CapitalAvaana CapitalBoxGroupClaypond Capital+7 more
Developing therapeutic peptides targeting rare endocrine diseases (past investment).
Co-investorsAndera PartnersATEM Capital FundCTI Life Sciences Fund L.P.EQT Life SciencesKurma PartnersOctalfa+4 more
Convergent provides an AI simulation platform for enterprise training and skill development.
AI & Machine LearningEnterprise SoftwareHR TechSaaSLondon, GB
Co-investorsTechstarsAndreessen HorowitzRA Capital
Evozyne designs and builds engineered protein therapeutics using an AI-native platform, focusing on treatments for immune-mediated diseases.
AI & Machine LearningBiotechDeep TechHealthtechChicago, US
Aris Theologis(Executive Officer, Director)inDarien Parhad(Executive Officer)Patrick J. Morris(Executive Officer, Director)Marc Yoskowitz(CEO)inRama Ranganathan(Founder)Andrew Ferguson(Founder)
Co-investorsParagon Biosciences LLCIn-Q-TelNVIDIAValor Equity PartnersFidelity InvestmentsNVentures
MagentaMed develops the Elevate percutaneous Left Ventricular Assist Device (pLVAD), a low-profile, high-flow arterial pump for temporary mechanical circulatory support.
HardwareHealthtechMedical DevicesKadima, IL
Yosi Tuval(MSc – Co-Founder & CTO)Ehud Schwammenthal(MD, PhD – Co-Founder & CMO)inDavid Israeli(MD, MBA – Chairman & CEO)in
Co-investorsALIVE Israel HealthTech FundFresenius Medical Care VenturesNew Enterprise Associates (NEA)RA CapitalViking GlobalPitango
Nanotronics develops technology for manufacturing, positioning customers to gain an edge in production processes.
Advanced ManufacturingAI & Machine LearningDeep TechHardwareSemiconductorsBrooklyn, US
John Putman(Founder)inMatthew Putman(Founder)in
BoardPeter Thiel(Director)in
Co-investorsFounders FundMetaplanetInvestment Corporation of Dubai (ICD)Mana Ventures
Developing safe, long-lasting gene therapy treatments in a redosable, non-viral format.
Louis Breton(Founder)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.